Annual report [Section 13 and 15(d), not S-K Item 405]

Patent Assignment and Royalty Agreement (Details Narrative)

v3.26.1
Patent Assignment and Royalty Agreement (Details Narrative) - USD ($)
$ / shares in Thousands
12 Months Ended
Sep. 02, 2025
Dec. 31, 2025
Dec. 31, 2024
Revenue  
Acquisition price $ 1,750,000    
Stock converted value    
Contingent consideration fair value   9,380,000  
Series I Convertible Preferred Stock [Member]      
Stock converted 747,362    
Stock converted value $ 2,700,000 $ 2,697,977  
Stock price $ 260